📰 Intelligence Analysis News
Page 45 - Intelligence Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Intelligence Analysis. Real-time updates on events, politics, business and more.
February 28, 2022
LAS VEGAS, Feb. 28, 2022 /PRNewswire/ -- The launch of key Warm Autoimmune Hemolytic Anemia (WAIHA) assets such as Fostamitinib (Rigel Pharmaceuticals) and APL2 (Apellis Pharmaceuticals), which
February 23, 2022
The Night Vision Disturbances is an untapped market with only single-player having a late-stage asset in the pipeline. There has been a significant lack of effective emerging therapies in the
February 23, 2022
/PRNewswire/ -- DelveInsights Night Vision Disturbances Market Insights report proffers a detailed comprehension of Night Vision Disturbances market size by...
February 19, 2022
The U.S. has technical information linking Russia to the attacks, says the deputy national security adviser Anne Neuberger.
February 5, 2022
As a former British intelligence officer, I?m worried the system is now failing When classified intelligence is handed to politicians or t
February 5, 2022
As a former British intelligence officer, I?m worried the system is now failing When classified intelligence is handed to politicians or t
January 31, 2022
/PRNewswire/ -- DelveInsights Food Allergy Market Insights report proffers a detailed comprehension of Food Allergy market size by treatment, epidemiology,...
January 31, 2022
- The recent launch of Aimmune's Palforzia has paved the way for other key players to invest in the food allergy treatment market landscape. Further, the FDA-approved fast track designation
January 12, 2022
/PRNewswire/ -- DelveInsights Allergic Rhinitis Market Insights report proffers a detailed comprehension of Allergic Rhinitis market size by treatment,...
January 12, 2022
/PRNewswire/ -- DelveInsights Allergic Rhinitis Market Insights report proffers a detailed comprehension of Allergic Rhinitis market size by treatment,...